Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -59,681 | -204,703 | -145,893 | -119,424 |
| Depreciation Amortization | 485 | 640 | 222 | 221 |
| Other Working Capital | 5,401 | 3,266 | -956 | -436 |
| Other Operating Activity | 2,769 | 115,328 | 107,501 | 94,020 |
| Operating Cash Flow | $-51,026 | $-85,469 | $-39,126 | $-25,619 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,681 | -3,912 | -3,634 | -2,292 |
| Other Investing Activity | -71,527 | -1,426 | -1,405 | 2,742 |
| Investing Cash Flow | $-73,208 | $-5,338 | $-5,039 | $450 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 34 | 206,424 | 203,920 | 140,809 |
| Financing Cash Flow | $34 | $206,424 | $203,920 | $140,809 |
| Exchange Rate Effect | 11,241 | -6,327 | -2,641 | -8,190 |
| Beginning Cash Position | 254,325 | 158,426 | 156,356 | 47,353 |
| End Cash Position | 141,366 | 267,716 | 313,470 | 154,803 |
| Net Cash Flow | $-112,959 | $109,290 | $157,114 | $107,450 |
| Free Cash Flow | ||||
| Operating Cash Flow | -51,026 | -85,469 | -39,126 | -25,619 |
| Free Cash Flow | -51,026 | -85,469 | -39,126 | -25,619 |